Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. CELZ
CELZ logo

CELZ

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CELZ News

Creative Medical Achieves Second International Nonproprietary Name Milestone

Feb 10 2026Newsfilter

Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes

Jan 16 2026NASDAQ.COM

Creative Medical Technologies Reports Positive CELZ-201 Interim Data, Significant Pain Relief Achieved

Jan 13 2026NASDAQ.COM

Creative Medical Reports Positive Interim Data for CELZ-201 in Chronic Back Pain Trial

Jan 13 2026Globenewswire

Creative Medical Receives Approval to Advance Veterans' Burn Pit Initiative

Jan 06 2026Globenewswire

Creative Medical Completes Enrollment for ADAPT Trial on Chronic Lower Back Pain

Dec 18 2025NASDAQ.COM

Creative Medical Completes Patient Enrollment in CELZ-201 Clinical Trial

Dec 17 2025Newsfilter

Creative Medical Completes Patient Enrollment in CELZ-201 Clinical Trial for Chronic Back Pain

Dec 17 2025Globenewswire

Creative Medical Secures WHO Approval for Olastrocel, Enhancing Global Development Prospects

Dec 02 2025Newsfilter

Creative Medical Secures WHO Approval for Olastrocel Name, Enhancing Global Development

Dec 02 2025Globenewswire

Creative Medical Technology Holdings, Inc. Launches Innovative Regenerative BioDefense Program for U.S. Veterans Affected by Burn Pits

Oct 30 2025Newsfilter

Creative Medical Technology Holdings Sends Letter to Shareholders

Oct 27 2025Newsfilter

Creative Medical Technology Holdings Celebrates 2025 Nobel Prize Winners for Advances in Regulatory T Cell Research

Oct 07 2025Newsfilter

US Stocks Likely To Open Lower A Day After Nasdaq Hits Record High: Nvidia, Kellogg, Klotho In Focus

Jul 10 2025Benzinga

Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket

Jul 10 2025Benzinga

Creative Medical Technology files to sell 1.8M shares of common for holders

Apr 02 2025Business Insider